941 related articles for article (PubMed ID: 26090067)
21. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study.
Mohammed Y; Bekele A
BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241
[TBL] [Abstract][Full Text] [Related]
22. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal.
Shrestha AC; Ghimire P; Tiwari BR; Rajkarnikar M
J Infect Dev Ctries; 2009 Dec; 3(10):794-7. PubMed ID: 20009282
[TBL] [Abstract][Full Text] [Related]
23. The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C virus, and human immunodeficiency virus.
Guo Z; Fu P; Yin Y; Wang F; Yin Y; Wang J; Liu Y
Transfusion; 2017 Mar; 57(3pt2):832-840. PubMed ID: 28164313
[TBL] [Abstract][Full Text] [Related]
24. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
Roth WK; Weber M; Seifried E
Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
[TBL] [Abstract][Full Text] [Related]
25. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus.
Gonçales FL; Pereira JS; Da Silva C; Thomaz GR; Pavan MH; Fais VC; Magna LA; Gonçales NS
Clin Diagn Lab Immunol; 2003 Jul; 10(4):718-20. PubMed ID: 12853411
[TBL] [Abstract][Full Text] [Related]
28. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
30. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India.
Makroo RN; Hegde V; Chowdhry M; Bhatia A; Rosamma NL
Indian J Med Res; 2015 Sep; 142(3):317-22. PubMed ID: 26458348
[TBL] [Abstract][Full Text] [Related]
33. The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors.
Rocha D; Andrade E; Godoy DT; Fontana-Maurell M; Costa E; Ribeiro M; Ferreira AGP; Brindeiro R; Tanuri A; Alvarez P
Transfusion; 2018 Apr; 58(4):862-870. PubMed ID: 29383720
[TBL] [Abstract][Full Text] [Related]
34. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
35. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
[TBL] [Abstract][Full Text] [Related]
36. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
37. Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan.
Souan L; Siag M; Al-Salahat H; Al-Atrash T; Sughayer MA
BMC Infect Dis; 2021 May; 21(1):508. PubMed ID: 34059011
[TBL] [Abstract][Full Text] [Related]
38. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria.
Buseri FI; Muhibi MA; Jeremiah ZA
Blood Transfus; 2009 Oct; 7(4):293-9. PubMed ID: 20011640
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
[TBL] [Abstract][Full Text] [Related]
40. How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus?
Rabenau H; Schütz R; Berger A; Doerr HW; Weber B
Infusionsther Transfusionsmed; 1996 Jun; 23(3):124-30. PubMed ID: 8782708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
